John Ng

John Ng is a seasoned CMC Consultant at CMC Biotech Co., Ltd. since June 2018, specializing in strategic and practical support for emerging biotech companies. With a strong foundation in both scientific and business elements of drug development, John Ng emphasizes cost-effective and timely pre-clinical and clinical strategies that enhance execution for resource-constrained companies. Prior experiences include serving as Director of CMC at Comentis, holding positions at Anadys Pharmaceuticals and Amgen as well as a long tenure as Science Fellow at Searle. John Ng earned a PhD in Chemistry from the University of Illinois Urbana-Champaign and also studied Organic Chemistry at Brandeis University.